YANG, DI Statistiche
YANG, DI
DIPARTIMENTO DI MATEMATICA
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
2017-01-01 Suenaga, M; Schirripa, M; Cao, S; Zhang, W; Yang, D; Murgioni, S; Rossini, D; Marmorino, F; Mennitto, A; Ning, Y; Okazaki, S; Berger, M D; Miyamoto, Y; Gopez, R; Barzi, A; Yamaguchi, T; Loupakis, F; Lenz, H-J
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer
2015-01-01 Volz, N. B; Stintzing, S.; Zhang, W.; Yang, Di; Ning, Y.; Wakatsuki, T.; El Khoueiry, R. E.; Li, J. E.; Kardosh, A.; Loupakis, Fotios; Cremolini, Chiara; Falcone, Alfredo; Scherer, S. J.; Lenz, H. J.
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: Results from TRIBE and FIRE3 trials
2015-01-01 Sunakawa, Y.; Stintzing, S.; Cao, S.; Heinemann, V.; Cremolini, Chiara; Falcone, Alfredo; Yang, Di; Zhang, W.; Ning, Y.; Stremitzer, S.; Matsusaka, S.; Yamauchi, S.; Parekh, A.; Okazaki, S.; Berger, M. D.; Graver, S.; Mendez, A.; Scherer, S. J.; Loupakis, Fotios; Lenz, H. J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer | 1-gen-2017 | Suenaga, M; Schirripa, M; Cao, S; Zhang, W; Yang, D; Murgioni, S; Rossini, D; Marmorino, F; Mennitto, A; Ning, Y; Okazaki, S; Berger, M D; Miyamoto, Y; Gopez, R; Barzi, A; Yamaguchi, T; Loupakis, F; Lenz, H-J | |
| Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer | 1-gen-2015 | Volz, N. B; Stintzing, S.; Zhang, W.; Yang, Di; Ning, Y.; Wakatsuki, T.; El Khoueiry, R. E.; Li, J. E.; Kardosh, A.; Loupakis, Fotios; Cremolini, Chiara; Falcone, Alfredo; Scherer, S. J.; Lenz, H. J. | |
| Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: Results from TRIBE and FIRE3 trials | 1-gen-2015 | Sunakawa, Y.; Stintzing, S.; Cao, S.; Heinemann, V.; Cremolini, Chiara; Falcone, Alfredo; Yang, Di; Zhang, W.; Ning, Y.; Stremitzer, S.; Matsusaka, S.; Yamauchi, S.; Parekh, A.; Okazaki, S.; Berger, M. D.; Graver, S.; Mendez, A.; Scherer, S. J.; Loupakis, Fotios; Lenz, H. J. |